Nuzenio

Ocular

Ocular news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 20:05:00 GMTOcular Therapeutix Options for New Hires Carry $8.40 Price - Stock TitanStock Titan · Fri, 07 Aug 2026 20:05:00 GMTPersistent ocular symptoms following COVID-19 - Association of Optometrists (AOP)Association of Optometrists (AOP) · Fri, 07 Aug 2026 16:38:22 GMTHere's What Analysts Are Forecasting For Ocular Therapeutix, Inc. (NASDAQ:OCUL) After Its Second-Quarter Results - simplywall.stsimplywall.st · Thu, 06 Aug 2026 11:40:25 GMTUse of PDE5 Inhibitor Tied to Increased Glaucoma Risk - medpagetoday.commedpagetoday.com · Wed, 05 Aug 2026 18:43:35 GMTSticking With This Ocular Therapeutix Price Target as Key Treatment Moves Forward - TheStreet ProTheStreet Pro · Mon, 03 Aug 2026 14:30:00 GMTStudy explores diagnostic utility of ocular ultrasound in the emergency department - Vanderbilt Health NewsVanderbilt Health News · Mon, 03 Aug 2026 13:31:13 GMT

Timeline

Fri, 07 Aug 2026 20:05:00 GMTOcular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Fri, 07 Aug 2026 20:05:00 GMTOcular Therapeutix Options for New Hires Carry $8.40 Price - Stock Titan
Fri, 07 Aug 2026 16:38:22 GMTPersistent ocular symptoms following COVID-19 - Association of Optometrists (AOP)
Thu, 06 Aug 2026 11:40:25 GMTHere's What Analysts Are Forecasting For Ocular Therapeutix, Inc. (NASDAQ:OCUL) After Its Second-Quarter Results - simplywall.st
Wed, 05 Aug 2026 18:43:35 GMTUse of PDE5 Inhibitor Tied to Increased Glaucoma Risk - medpagetoday.com
Mon, 03 Aug 2026 14:30:00 GMTSticking With This Ocular Therapeutix Price Target as Key Treatment Moves Forward - TheStreet Pro

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ocular.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.